BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15145450)

  • 1. Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes.
    Frankenfeld CL; McTiernan A; Tworoger SS; Atkinson C; Thomas WK; Stanczyk FZ; Marcovina SM; Weigle DS; Weiss NS; Holt VL; Schwartz SM; Lampe JW
    J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):399-408. PubMed ID: 15145450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes.
    Frankenfeld CL; McTiernan A; Thomas WK; LaCroix K; McVarish L; Holt VL; Schwartz SM; Lampe JW
    Maturitas; 2006 Feb; 53(3):315-24. PubMed ID: 16019168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States.
    Atkinson C; Newton KM; Stanczyk FZ; Westerlind KC; Li L; Lampe JW
    Cancer Causes Control; 2008 Dec; 19(10):1085-93. PubMed ID: 18478336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.
    Frankenfeld CL; McTiernan A; Aiello EJ; Thomas WK; LaCroix K; Schramm J; Schwartz SM; Holt VL; Lampe JW
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1156-62. PubMed ID: 15247126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daidzein-metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China.
    Guo K; Zhang B; Chen C; Uchiyama S; Ueno T; Chen Y; Su Y
    Br J Nutr; 2010 Jul; 104(1):118-24. PubMed ID: 20205965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary equol excretion in relation to 2-hydroxyestrone and 16alpha-hydroxyestrone concentrations: an observational study of young to middle-aged women.
    Atkinson C; Skor HE; Dawn Fitzgibbons E; Scholes D; Chen C; Wähälä K; Schwartz SM; Lampe JW
    J Steroid Biochem Mol Biol; 2003 Jul; 86(1):71-7. PubMed ID: 12943746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart.
    Frankenfeld CL; Atkinson C; Thomas WK; Gonzalez A; Jokela T; Wähälä K; Schwartz SM; Li SS; Lampe JW
    Br J Nutr; 2005 Dec; 94(6):873-6. PubMed ID: 16351761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer.
    Duncan AM; Merz-Demlow BE; Xu X; Phipps WR; Kurzer MS
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):581-6. PubMed ID: 10868692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Being overweight or obese is associated with harboring a gut microbial community not capable of metabolizing the soy isoflavone daidzein to O-desmethylangolensin in peri- and post-menopausal women.
    Miller LM; Lampe JW; Newton KM; Gundersen G; Fuller S; Reed SD; Frankenfeld CL
    Maturitas; 2017 May; 99():37-42. PubMed ID: 28364866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of soy supplementation on sex steroids and vascular inflammation markers in postmenopausal women using tibolone: role of equol production capability.
    Törmälä R; Appt S; Clarkson TB; Mueck AO; Seeger H; Mikkola TS; Ylikorkala O
    Climacteric; 2008 Oct; 11(5):409-15. PubMed ID: 18781486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Equol-producing phenotype and in relation to serum sex hormones among healthy adults in Beijing].
    Liu B; Qin L; Liu A; Shi Y; Wang P
    Wei Sheng Yan Jiu; 2011 Nov; 40(6):727-31. PubMed ID: 22279666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community.
    Possemiers S; Bolca S; Eeckhaut E; Depypere H; Verstraete W
    FEMS Microbiol Ecol; 2007 Aug; 61(2):372-83. PubMed ID: 17506823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women.
    Liu ZM; Ho SC; Chen YM; Liu J; Woo J
    PLoS One; 2014; 9(2):e87861. PubMed ID: 24533060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
    Védrine N; Mathey J; Morand C; Brandolini M; Davicco MJ; Guy L; Rémésy C; Coxam V; Manach C
    Eur J Clin Nutr; 2006 Sep; 60(9):1039-45. PubMed ID: 16482068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States.
    Atkinson C; Newton KM; Aiello Bowles EJ; Lehman CD; Stanczyk FZ; Westerlind KC; Li L; Lampe JW
    Breast Cancer Res Treat; 2009 Aug; 116(3):587-94. PubMed ID: 18821061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.
    Frankenfeld CL; Atkinson C; Wähälä K; Lampe JW
    Eur J Clin Nutr; 2014 Apr; 68(4):526-30. PubMed ID: 24569543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation.
    Törmälä RM; Appt S; Clarkson TB; Tikkanen MJ; Ylikorkala O; Mikkola TS
    Climacteric; 2007 Dec; 10(6):471-9. PubMed ID: 18049940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women.
    Ishiwata N; Melby MK; Mizuno S; Watanabe S
    Menopause; 2009; 16(1):141-8. PubMed ID: 19131846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-desmethylangolensin: the importance of equol's lesser known cousin to human health.
    Frankenfeld CL
    Adv Nutr; 2011 Jul; 2(4):317-24. PubMed ID: 22332073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children.
    Hoey L; Rowland IR; Lloyd AS; Clarke DB; Wiseman H
    Br J Nutr; 2004 Apr; 91(4):607-16. PubMed ID: 15035688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.